These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Regulation of central 5-HT2A receptors: a review of in vivo studies. Eison AS; Mullins UL Behav Brain Res; 1996; 73(1-2):177-81. PubMed ID: 8788498 [TBL] [Abstract][Full Text] [Related]
8. Corticosterone regulation of 5-HT2A receptor-mediated behaviors: attenuation by melatonin. Gorzalka BB; Brotto LA; Hong JJ Physiol Behav; 1999 Sep; 67(3):439-42. PubMed ID: 10497964 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I; Johansson C; Ogren SO Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333 [TBL] [Abstract][Full Text] [Related]
10. Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis. Watts SW; Cox DA; Johnson BG; Schoepp DD; Cohen ML J Pharmacol Exp Ther; 1994 Nov; 271(2):832-44. PubMed ID: 7965803 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Ashby CR; Edwards E; Wang RY Synapse; 1994 Jul; 17(3):173-81. PubMed ID: 7974200 [TBL] [Abstract][Full Text] [Related]
12. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Sanders-Bush E; Burris KD; Knoth K J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634 [TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT Nakamura Y; Kitamura Y; Sumiyoshi Y; Naito N; Kan S; Ushio S; Miyazaki I; Asanuma M; Sendo T J Pharmacol Sci; 2018 Nov; 138(3):192-197. PubMed ID: 30360947 [TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774 [TBL] [Abstract][Full Text] [Related]
15. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine. Kuoppamäki M; Pälvimäki EP; Syvälahti E; Hietala J Eur J Pharmacol; 1994 Apr; 255(1-3):91-7. PubMed ID: 8026557 [TBL] [Abstract][Full Text] [Related]
16. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives. Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661 [TBL] [Abstract][Full Text] [Related]
17. Regulation of serotonin2A receptor expression by an antisense oligodeoxynucleotide. Scalzitti JM; Berg KA; Kratowicz SA; Hensler JG J Neurochem; 1998 Oct; 71(4):1457-63. PubMed ID: 9751178 [TBL] [Abstract][Full Text] [Related]
18. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat. Dugovic C; Leysen JE; Wauquier A Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097 [TBL] [Abstract][Full Text] [Related]
19. Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine. Cabrera TM; Battaglia G J Pharmacol Exp Ther; 1994 May; 269(2):637-45. PubMed ID: 8182530 [TBL] [Abstract][Full Text] [Related]
20. Long-lasting change in 5-HT2A receptor-mediated behavior in rats after a single footshock. Izumi T; Suzuki K; Inoue T; Li XB; Maki Y; Muraki I; Kitaichi Y; Hashimoto S; Koyama T Eur J Pharmacol; 2002 Oct; 452(2):199-204. PubMed ID: 12354570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]